Skip to main content
Top

Drugs

Issue 6/2025

Content (11 Articles)

Differentiating IL-23 Inhibitors in Crohn’s Disease

Olga Maria Nardone, Sudheer K. Vuyyuru, Yuhong Yuan, Jurij Hanzel, Vipul Jairath

PI3K Inhibitors as Potential Therapeutic Agents for the Treatment of COPD with Associated Atherosclerosis

Mario Cazzola, Clive Page, Paola Rogliani, Luigino Calzetta, Maria Gabriella Matera

Renal Safety Assessment of Lipid-Lowering Drugs: Between Old Certainties and New Questions

Daniele Tramontano, Simone Bini, Carlo Maiorca, Alessia Di Costanzo, Martina Carosi, Jacopo Castellese, Ina Arizaj, Daniela Commodari, Stella Covino, Giorgia Sansone, Ilenia Minicocci, Marcello Arca, Laura D’Erasmo

Therapeutic Potential of Centhaquine Citrate, a Selective Alpha-2B Adrenoceptor Agonist, in the Management of Circulatory Shock

  • Open Access
  • Shock
  • Review Article

Matthieu Legrand, Amaresh Ranjan, Shruthi Rammohan, Daniel De Backer, Marlies Ostermann, Anil Gulati, Jean-Louis Vincent, Ashish K. Khanna

Lipid-Lowering Therapy and Cardiovascular Prevention in Elderly

  • Open Access
  • Statins
  • Review Article

Francesco Baratta, Federica Moscucci, Ilaria Lospinuso, Nicholas Cocomello, Alessandra Colantoni, Alessia Di Costanzo, Daniele Tramontano, Laura D’Erasmo, Daniele Pastori, Evaristo Ettorre, Maria Del Ben, Marcello Arca, Giovambattista Desideri

Garadacimab: First Approval

Simon Fung

Acoramidis: First Approval

Arnold Lee

Suzetrigine: First Approval

Susan J. Keam

Correction: Current and Emerging Therapies for Lysosomal Storage Disorders

  • Correction

Diego Agustín Abelleyra Lastoria, Sophie Keynes, Derralynn Hughes